세계의 면역 레퍼토리 시퀀싱 시장 - 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) : 컴포넌트별, 용도별, 최종 사용자별, 지역별

Immune Repertoire Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

US $ 4,995 ￦ 6,879,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,699,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,598,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

차세대 시퀀싱(NGS) 기술의 최근 발전은 면역 레퍼토리 시퀀싱 분야에서 획기적인 발견에 대한 길을 열었습니다. B 세포 수용체(BCR)와 T 세포 수용체(TCR)의 상보성 결정 영역을 조사하는 이 최첨단 기술은 외래 병원체에 대한 신체의 방어 메커니즘에 대한 우리의 이해에 혁명을 가져오고 있습니다.

면역 레퍼토리 시퀀싱은 침습성과 시료 요구량을 최소화하고 정확하고 민감한 플랫폼을 제공하며 관심 영역의 역동적인 뷰를 제공합니다. 앞으로 이 분야에서의 새로운 기법의 개발은 특히 현재의 기법에 비해 보다 종합적인 샘플 인사이트를 제공할 수 있다면 중심적인 역할을 담당하게 될 것입니다. 면역 레퍼토리 시퀀싱의 미래는 항원 결합 세포를 포함하여 더 작은 대상 집단에 대한 높은 차원의 상세한 정보를 제공하는 단일 셀 접근법이 주류가 될 것으로 예상됩니다.

최근의 예측에 따르면 세계의 면역 레퍼토리 시퀀싱 시장은 CAGR 7.3%라는 경이적인 성장을 이루며, 2026년 말까지 1억 7,300만 달러에 달할 것으로 예측되고 있습니다. 금액 기준으로는 북미가 압도적인 지역 시장으로 부상하고 아시아태평양에서도 강력한 성장이 전망되고 있습니다.

북미에서는 암이나 감염증과의 싸움에서 면역요법에 대한 수요가 증가함에 따라 미국이 시장을 선도할 것으로 예상됩니다. 미국 국립암 연구소가 강조하고 있듯이, 면역 레퍼토리 시퀀싱법의 개발은 암에 대한 진보에 있어 매우 중요한 역할을 할 것으로 기대되고 있습니다.

유럽은 면역 레퍼토리 시퀀싱에서 두 번째로 우세한 지역 시장으로, 헬스케어 지출 증가와 정부 자금이 그 원동력이 되고 있습니다. 이 지역은 경쟁 구도가 치열하여 많은 제조업체들이 시장 성장에 기여하고 있습니다. 또한 게놈 시퀀싱의 가격 인하가 면역 레퍼토리 시퀀싱 수요에 박차를 가하고 있습니다.

아시아태평양, 특히 중국과 일본은 세계의 면역 레퍼토리 시퀀싱 시장에서 현저한 성장을 이루고 있습니다. 이 지역의 국제 공동 연구와 기술의 진보에 힘입어 이 기술의 채용이 증가하고 있습니다. 라틴아메리카는 첨단 제품의 도입과 감염의 이환율 상승에 힘입어 성장하고 있습니다.

이 보고서는 세계의 면역 레퍼토리 시퀀싱 시장을 조사했으며, 시장 개요와 함께 구성 요소별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의 및 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아의 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

• 세계의 면역 레퍼토리 시퀀싱 시장 전망 : 컴포넌트별, 금액(100만 달러)(2018-2031년)
• 세계의 면역 레퍼토리 시퀀싱 시장 전망 : 용도별, 금액(100만 달러)(2018-2031년)
• 세계의 면역 레퍼토리 시퀀싱 시장 전망 : 최종 사용자별, 금액(100만 달러)(2018-2031년)
• 세계의 면역 레퍼토리 시퀀싱 시장 전망 : 지역별, 금액(100만 달러)(2018-2031년)

제4장 북미의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

제5장 유럽의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

제6장 아시아태평양의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

제7장 라틴아메리카의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

제8장 중동 및 아프리카의 면역 레퍼토리 시퀀싱 시장 전망(2018-2031년)

제9장 경쟁 구도

• 최종 사용자별 및 용도별 히트맵
• 제조업체와 용도별 히트 맵
• 기업의 시장 점유율 분석(2023년)
• 경쟁력 대시보드
• 기업 프로파일
  • Illumina, Inc.
  • Pacific Biosciences of California, Inc
  • Agilent Technologies, Inc
  • Oxford Nanopore Technologies, Ltd
  • QIAGEN NV
  • Thermo Fisher Scientific
  • BGI
  • Takara Bio, Inc
  • F. Hoffmann-La Roche Ltd

제10장 부록

AJY

영문 목차

영문목차

Recent advancements in next-generation sequencing (NGS) technology have paved the way for groundbreaking discoveries in the field of immune repertoire sequencing. This cutting-edge technique, which probes the complementarity-determining regions of B-cell receptors (BCRs) and T-cell receptors (TCRs), is revolutionizing our understanding of the body's defense mechanisms against foreign agents.

Immune Repertoire Sequencing Unveils a World of Opportunities

Immune repertoire sequencing offers an accurate and sensitive platform with minimal invasiveness and sample requirement, providing a dynamic view of the region of interest. Looking ahead, the development of new methods in this field is poised to take center stage, particularly if they can offer more comprehensive sample insights compared to current techniques. The future of immune repertoire sequencing is expected to be dominated by single-cell approaches, offering high-dimensional and in-depth information on smaller populations of interest, including antigen-binding cells.

Market Projections and Regional Dominance

According to recent projections, the global immune repertoire sequencing market is set to grow at an impressive CAGR of 7.3% and is anticipated to reach a valuation of US$ 173.0 million by the end of 2026. In terms of value, North America is poised to emerge as the dominant regional market, with strong growth anticipated in Asia Pacific.

In North America, the United States is expected to lead the way due to a growing demand for immunotherapy in the fight against cancer and infectious diseases. Developments in immune repertoire sequencing methods are expected to play a pivotal role in the progress against cancer, as highlighted by the U.S. National Cancer Institute.

Europe is the second dominant regional market for immune repertoire sequencing, driven by increased healthcare expenditure and government funding. This region boasts a highly competitive landscape, with numerous manufacturers contributing to the market's growth. Additionally, price reductions in genome sequencing have spurred the demand for immune repertoire sequencing.

Asia-Pacific, specifically China and Japan, is witnessing significant growth in the global immune repertoire sequencing market. The adoption of this technology is on the rise, supported by international collaborations and technological advancements in the region. Latin America is experiencing growth fueled by advanced product introductions and the rising incidence of infectious diseases.

Conversely, the Middle East & Africa is expected to be the least attractive market due to challenges such as a lack of skilled personnel and limited internet access for data analysis. However, price reductions and international collaborations may spur future growth in this region.

Unlocking the Potential of Immune Repertoire Sequencing

High-throughput sequencing of immunoglobulin and TCR sequences is opening up numerous opportunities for advancing our knowledge of human biology and medicine. Immune repertoire sequencing holds immense promise in biomarker discovery, vaccine development, and transplant selectivity. However, it also comes with its share of challenges, including the need for new sequenced databases, computational algorithms, and advanced software for comprehensive data analysis.

In conclusion, the ever-evolving field of immune repertoire sequencing is poised for continuous growth, driven by scientific breakthroughs in TCR and BCR repertoire research. These developments will serve as the foundation for new clinical applications in personalized medicine, providing deeper insights into the behavior and response of adaptive immunity.

Table of Contents

1. Executive Summary

• 1.1. Global Immune Repertoire Sequencing Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 3.1. Global Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Assay Kits
      • 3.1.1.1.1. TCR Kits
      • 3.1.1.1.2. BCR Kits
    • 3.1.1.2. Software & Services
      • 3.1.1.2.1. Analytical Software
      • 3.1.1.2.2. Sequencing Services
      • 3.1.1.2.3. Data Analysis Services
• 3.2. Global Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Biomarker Discovery
    • 3.2.1.2. Infectious Diseases
    • 3.2.1.3. Vaccine Development and efficacy
    • 3.2.1.4. Cancer Immunotherapy
    • 3.2.1.5. Autoimmune Disease
    • 3.2.1.6. Transplant Rejection and Tolerance
    • 3.2.1.7. Others
• 3.3. Global Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. Academic Institutes
    • 3.3.1.2. Research Centres
• 3.4. Global Immune Repertoire Sequencing Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
  • 3.4.1. Key Highlights
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. Asia Pacific
    • 3.4.1.4. Latin America
    • 3.4.1.5. Middle East & Africa

4. North America Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 4.1. North America Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Assay Kits
      • 4.1.1.1.1. TCR Kits
      • 4.1.1.1.2. BCR Kits
    • 4.1.1.2. Software & Services
      • 4.1.1.2.1. Analytical Software
      • 4.1.1.2.2. Sequencing Services
      • 4.1.1.2.3. Data Analysis Services
• 4.2. North America Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Biomarker Discovery
    • 4.2.1.2. Infectious Diseases
    • 4.2.1.3. Vaccine Development and efficacy
    • 4.2.1.4. Cancer Immunotherapy
    • 4.2.1.5. Autoimmune Disease
    • 4.2.1.6. Transplant Rejection and Tolerance
    • 4.2.1.7. Others
• 4.3. North America Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Academic Institutes
    • 4.3.1.2. Research Centres
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis
• 4.4. North America Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S. Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 4.4.1.2. U.S. Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 4.4.1.3. U.S. Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.1.4. Canada Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 4.4.1.5. Canada Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 4.4.1.6. Canada Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
  • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 5.1. Europe Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Assay Kits
      • 5.1.1.1.1. TCR Kits
      • 5.1.1.1.2. BCR Kits
    • 5.1.1.2. Software & Services
      • 5.1.1.2.1. Analytical Software
      • 5.1.1.2.2. Sequencing Services
      • 5.1.1.2.3. Data Analysis Services
• 5.2. Europe Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Biomarker Discovery
    • 5.2.1.2. Infectious Diseases
    • 5.2.1.3. Vaccine Development and efficacy
    • 5.2.1.4. Cancer Immunotherapy
    • 5.2.1.5. Autoimmune Disease
    • 5.2.1.6. Transplant Rejection and Tolerance
    • 5.2.1.7. Others
• 5.3. Europe Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Academic Institutes
    • 5.3.1.2. Research Centres
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis
• 5.4. Europe Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. Germany Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.2. Germany Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.3. Germany Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.4. U.K. Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.5. U.K. Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.6. U.K. Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.7. France Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.8. France Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.9. France Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.10. Italy Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.11. Italy Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.12. Italy Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.13. Turkey Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.14. Turkey Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.15. Turkey Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.16. Russia Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.17. Russia Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.18. Russia Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1.19. Rest of Europe Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 5.4.1.20. Rest of Europe Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 5.4.1.21. Rest of Europe Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Assay Kits
      • 6.1.1.1.1. TCR Kits
      • 6.1.1.1.2. BCR Kits
    • 6.1.1.2. Software & Services
      • 6.1.1.2.1. Analytical Software
      • 6.1.1.2.2. Sequencing Services
      • 6.1.1.2.3. Data Analysis Services
• 6.2. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Biomarker Discovery
    • 6.2.1.2. Infectious Diseases
    • 6.2.1.3. Vaccine Development and efficacy
    • 6.2.1.4. Cancer Immunotherapy
    • 6.2.1.5. Autoimmune Disease
    • 6.2.1.6. Transplant Rejection and Tolerance
    • 6.2.1.7. Others
• 6.3. Asia Pacific Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Academic Institutes
    • 6.3.1.2. Research Centres
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. Asia Pacific Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. China Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.2. China Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.3. China Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.4. Japan Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.5. Japan Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.6. Japan Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.7. South Korea Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.8. South Korea Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.9. South Korea Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.10. India Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.11. India Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.12. India Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.13. Southeast Asia Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.14. Southeast Asia Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.15. Southeast Asia Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1.16. Rest of Asia Pacific Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 6.4.1.17. Rest of Asia Pacific Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 6.4.1.18. Rest of Asia Pacific Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 7.1. Latin America Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Assay Kits
      • 7.1.1.1.1. TCR Kits
      • 7.1.1.1.2. BCR Kits
    • 7.1.1.2. Software & Services
      • 7.1.1.2.1. Analytical Software
      • 7.1.1.2.2. Sequencing Services
      • 7.1.1.2.3. Data Analysis Services
• 7.2. Latin America Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 7.2.1.1. Biomarker Discovery
  • 7.2.1.2. Infectious Diseases
  • 7.2.1.3. Vaccine Development and efficacy
  • 7.2.1.4. Cancer Immunotherapy
  • 7.2.1.5. Autoimmune Disease
  • 7.2.1.6. Transplant Rejection and Tolerance
  • 7.2.1.7. Others
• 7.3. Latin America Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Academic Institutes
    • 7.3.1.2. Research Centres
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Latin America Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Brazil Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 7.4.1.2. Brazil Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.3. Brazil Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.4. Mexico Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 7.4.1.5. Mexico Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.6. Mexico Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.7. Argentina Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 7.4.1.8. Argentina Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.9. Argentina Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1.10. Rest of Latin America Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 7.4.1.11. Rest of Latin America Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 7.4.1.12. Rest of Latin America Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Immune Repertoire Sequencing Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Component, Value (US$ Mn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Assay Kits
      • 8.1.1.1.1. TCR Kits
      • 8.1.1.1.2. BCR Kits
    • 8.1.1.2. Software & Services
      • 8.1.1.2.1. Analytical Software
      • 8.1.1.2.2. Sequencing Services
      • 8.1.1.2.3. Data Analysis Services
• 8.2. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Biomarker Discovery
    • 8.2.1.2. Infectious Diseases
    • 8.2.1.3. Vaccine Development and efficacy
    • 8.2.1.4. Cancer Immunotherapy
    • 8.2.1.5. Autoimmune Disease
    • 8.2.1.6. Transplant Rejection and Tolerance
    • 8.2.1.7. Others
• 8.3. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Academic Institutes
    • 8.3.1.2. Research Centres
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Middle East & Africa Immune Repertoire Sequencing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. GCC Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 8.4.1.2. GCC Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.3. GCC Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.4. South Africa Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 8.4.1.5. South Africa Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.6. South Africa Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.7. Egypt Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 8.4.1.8. Egypt Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.9. Egypt Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.10. Nigeria Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 8.4.1.11. Nigeria Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.12. Nigeria Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1.13. Rest of Middle East & Africa Immune Repertoire Sequencing Market by Component, Value (US$ Mn), 2018 - 2031
    • 8.4.1.14. Rest of Middle East & Africa Immune Repertoire Sequencing Market by Application, Value (US$ Mn), 2018 - 2031
    • 8.4.1.15. Rest of Middle East & Africa Immune Repertoire Sequencing Market by End User, Value (US$ Mn), 2018 - 2031
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. By End User vs by Application Heat map
• 9.2. Manufacturer vs by Application Heatmap
• 9.3. Company Market Share Analysis, 2023
• 9.4. Competitive Dashboard
• 9.5. Company Profiles
  • 9.5.1. Illumina, Inc.
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Product Portfolio
    • 9.5.1.3. Financial Overview
    • 9.5.1.4. Business Strategies and Development
  • 9.5.2. Pacific Biosciences of California, Inc
    • 9.5.2.1. Company Overview
    • 9.5.2.2. Product Portfolio
    • 9.5.2.3. Financial Overview
    • 9.5.2.4. Business Strategies and Development
  • 9.5.3. Agilent Technologies, Inc
    • 9.5.3.1. Company Overview
    • 9.5.3.2. Product Portfolio
    • 9.5.3.3. Financial Overview
    • 9.5.3.4. Business Strategies and Development
  • 9.5.4. Oxford Nanopore Technologies, Ltd
    • 9.5.4.1. Company Overview
    • 9.5.4.2. Product Portfolio
    • 9.5.4.3. Financial Overview
    • 9.5.4.4. Business Strategies and Development
  • 9.5.5. QIAGEN N.V.
    • 9.5.5.1. Company Overview
    • 9.5.5.2. Product Portfolio
    • 9.5.5.3. Financial Overview
    • 9.5.5.4. Business Strategies and Development
  • 9.5.6. Thermo Fisher Scientific
    • 9.5.6.1. Company Overview
    • 9.5.6.2. Product Portfolio
    • 9.5.6.3. Financial Overview
    • 9.5.6.4. Business Strategies and Development
  • 9.5.7. BGI
    • 9.5.7.1. Company Overview
    • 9.5.7.2. Product Portfolio
    • 9.5.7.3. Financial Overview
    • 9.5.7.4. Business Strategies and Development
  • 9.5.8. Takara Bio, Inc
    • 9.5.8.1. Company Overview
    • 9.5.8.2. Product Portfolio
    • 9.5.8.3. Financial Overview
    • 9.5.8.4. Business Strategies and Development
  • 9.5.9. F. Hoffmann-La Roche Ltd
    • 9.5.9.1. Company Overview
    • 9.5.9.2. Product Portfolio
    • 9.5.9.3. Financial Overview
    • 9.5.9.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료